Haemonetics Corp

HAENYSE · USD
119.93USD-4.18 (-3.37%)
7810

Haemonetics Corp (HAE) Expected Move

HAE expected move through Nov 20, 2026 is 6.6%, with 13 days to expiration. The implied range is $111.71 to $128.16, based on the previous trading day's options prices.

Read more

Tracking the HAE expected move helps you see how far Haemonetics Corp's options market is pricing the stock to travel over a given period — whether that's the next day, week, or earnings cycle. Haemonetics Corp's expected move is derived directly from option premiums and gives you an objective range to plan trades, set strikes, and manage risk. Use our scanner to monitor the HAE expected move for this week's options, in real time.

The expected move is typically calculated from at-the-money straddle prices (or a blend of straddles and strangles) and represents roughly a one-standard-deviation range over the chosen timeframe. For HAE, comparing the implied expected move to actual realized moves over similar windows tells you whether the options market has historically overestimated or underestimated volatility. The HAE expected move for this week's options pricing is especially useful for short-dated traders, earnings players, and anyone selling premium who needs to know where the market thinks Haemonetics Corp is unlikely to go.

Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system.

Iron condors, weekly premium sales, directional swing trades — they all live or die by where the market thinks the stock won't go. Our scanner tracks the HAE expected move across every expiration, benchmarks it against realized moves, and shows you when implied ranges are out of line with history. The Haemonetics Corp expected move for this week's options is the fastest read on short-term risk, which gives you a quick way to interpret what the options market thinks about HAE.

HAE Price

EARN
EM

Drag chart to pan. Drag axes to zoom.

ExpirationDTEExpected move (USD)Expected move (%)Upper priceLower price
Nov 20, 202613$8.236.6%$128.16$111.71
Dec 18, 202641$12.5510.1%$132.48$107.38
Jan 15, 202769$15.7812.7%$135.71$104.16
Mar 19, 2027132$24.6319.8%$144.56$95.31

As of Nov 5, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →